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Abstract. 
 
We previously showed that targeting of pro-
tein phosphatase 1 (PP1) to the nuclear envelope (NE)
by the A-kinase anchoring protein, AKAP149, corre-
lates with nuclear assembly of B-type lamins in vitro.
We demonstrate here that failure of AKAP149-medi-
ated assembly of B-type lamins into the nuclear lamina
at the end of mitosis is followed by apoptosis, and in-
duces expression of the gene encoding A-type lamins in
cells that normally do not express lamins A/C. In HeLa
cells, inhibition of PP1 association with the NE medi-
ated by a peptide containing the PP1-binding domain of
AKAP149 results in failure of B-type lamins to assem-
ble, and in their rapid caspase-dependent proteolysis.
However, assembly of lamins A/C is not affected.
Nonetheless, apoptosis follows within hours of nuclear
reformation after mitosis. In lymphoid KE37 cells,
which do not express lamins A/C, inhibition of B-type
lamin assembly triggers rapid synthesis and nuclear as-
sembly of both lamins A and C before apoptosis takes
 
place. The results indicate that nuclear assembly of
B-type lamins is essential for cell survival. They also
suggest that mistargeting of B-type lamins at the end of
mitosis elicits a tentative rescue process to assemble a
nuclear lamina in lymphoid cells that normally do not
express lamins A/C.
Key words: AKAP149 • apoptosis • lamin • mitosis •
nuclear envelope
 
Introduction
 
The nuclear lamina consists of a peri- and intranuclear
meshwork of intermediate filaments called lamins (Gruen-
baum et al., 2000). Lamins have been grouped into A and
B types based on their isoelectric points. Lamins A and C
are splice variants of a single lamin A (LMNA) gene,
whereas lamins B1 and B2 are encoded by two separate
LMNB1 and LMNB2 genes. A- and B-type lamins differ
in several ways, including their behavior at mitosis, post-
translational processing and expression patterns. B-type
lamins are expressed in all somatic cells, whereas A-type
lamins are absent in some nonterminally differentiated
cells (Guilly et al., 1987, 1990; Lin and Worman, 1997).
Nuclear lamins are implicated in various nuclear functions
(Ellis et al., 1997; Spann et al., 1997) and in severe forms of
muscular and lipodystrophies (Wilson, 2000).
The nuclear envelope (NE)
 
1
 
 is a dynamic structure that
breaks down at mitosis and reforms in an ordered manner
as a result of reversible phosphorylations of membrane,
lamina, and chromatin proteins (Collas and Courvalin,
2000). In an investigation of the mechanisms regulating
NE dynamics, we showed that the nuclear membrane
A-kinase anchoring protein, AKAP149, targets chroma-
tin-bound protein phosphatase 1 (PP1) to the NE upon
nuclear reformation in vitro, and that this correlates with
nuclear assembly of B-type lamins (Steen et al., 2000). In
vivo, A- and B-type lamins seem to assemble via distinct
pathways (Moir et al., 2000); however, the molecular
mechanism of lamin targeting to the NE is not elucidated.
Apoptosis is a regulated cell death process required for
tissue homeostasis (Kaufmann and Earnshaw, 2000). Ap-
optosis can be triggered by various external stimuli, but in-
tracellular execution signals are conserved (Ashkenazi and
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Dixit, 1998). Apoptosis is manifested by cell shrinkage and
chromatin condensation. Chromatin condensation is sec-
ondary to a series of nuclear events (Earnshaw, 1995) such
as DNA fragmentation and early caspase-dependent pro-
teolytic degradation of specific nuclear proteins that in-
clude lamins (Lazebnik et al., 1995; Takahashi et al., 1996).
In this study we investigated the consequences of PP1
mistargeting to the NE at the end of mitosis, using peptide
transfections into dividing fibroblasts and lymphoblastic
cells. We show that nuclear assembly of B-type lamins is
essential for cell survival, and that inhibition of lamin B as-
sembly triggers synthesis lamins A/C in lymphoblastic cells
that normally do not express the LMNA gene.
 
Materials and Methods
 
Antibodies
 
Anti-AKAP149 mAbs against human AKAP149 were from Transduction
Laboratories. mAb E-19 against PP1 was from Santa Cruz Biotechnology,
Inc. Rabbit antibodies against human LBR and a peptide of human lamin
B, and mAb XB10 (BAbCO) against human lamins A/C, were gifts from
B. Buendia and J.-C. Courvalin (Institut J. Monod, Paris, France)
(Chaudhary and Courvalin, 1993; Buendia and Courvalin, 1997). Anti-
lamin B antibodies did not distinguish between the lamin B1 and B2 iso-
forms, which were globally referred to as “lamin B” in the text. Anti-
emerin mAb MANEM 5 was donated by G. Morris (N.E. Wales Institute,
Wrexham, UK) (Manilal et al., 1999). Antibodies against poly(ADP)ribo-
syl polymerase (PARP) were from Boehringer.
 
Cells and Nuclei
 
HeLa cells were grown and synchronized in M phase with 1 
 
m
 
M nocoda-
zole for 18 h. The human lymphoblastic KE37 cell line (gift from M. Born-
ens, Institut Curie, Paris, France) was grown in suspension in RPMI 1640
(GIBCO BRL) (Guilly et al., 1987) and synchronized in M phase as for
HeLa cells. Nuclei and NEs were isolated from unsynchronized HeLa and
KE37 cells as described elsewhere (Collas et al., 1999).
 
Peptide Transfection
 
Synthetic PP1-BD (SSPKGVLFSS) and PP1-BD(V155A) (SSPK-
GALFSS) peptides were transfected into synchronized M phase HeLa or
KE37 cells using the transfection reagent DOTAP
 
®
 
 (Roche). Peptides (2
mM stocks) were diluted to 100 
 
m
 
M by mixing 1 
 
m
 
l peptide, 9 
 
m
 
l H
 
2
 
O, and
2 
 
m
 
l 20 mM Hepes (pH 7.5) with a premixed solution of 4 
 
m
 
l Hepes (pH
7.5) and 4 
 
m
 
l DOTAP. The mixture was incubated for 15 min in the dark,
10
 
5
 
 cells (at 10
 
6
 
 cells/ml) were added and incubated for 1.5 h at 37°C in a
5% CO
 
2
 
 atmosphere. 1 ml of PBS was added and cells were washed twice
by suspension and sedimentation. Cells were either cultured further (2–6 h,
as indicated) to allow exit from mitotic arrest, processed for immunofluo-
rescence or terminal deoxynucleotidyl transferase–mediated dUTP nick
end labeling (TUNEL) analysis, or dissolved in SDS sample buffer. Rou-
tinely, 90–100% of the cells incorporated the peptides, as judged by up-
take of fluorescein-conjugated PP1-BD(V155A) (data not shown).
 
Immunological Procedures
 
Western blotting analysis was performed as described earlier (Collas et al.,
1999) using anti-lamin B (1:1,000 dilution), anti-lamins A/C (1:500), anti-
PP1 (1:500), anti-AKAP149 (1: 250), and anti-PARP antibodies (1:250).
Immunoprecipitations of AKAP149 and PP1 from NEs were performed as
described (Steen et al., 2000), or after solubilization of the NEs in RIPA
buffer (10 mM Tris-HCl, pH 7.5, 100 mM NaCl, 1% Triton X-100, 1 mM
EDTA, 0.1% SDS, 0.1% sodium deoxycholate, 1 mM dithiothreitol) (see
Fig. 1 A). Immunofluorescence analysis of methanol-fixed cells was per-
formed as described previously (Steen et al., 2000). Antibodies were used
at a 1:100 dilution, and DNA was stained with 0.1 
 
m
 
g/ml Hoechst 33342. In
some experiments, proportions of fluorescently labeled cells were deter-
mined in 
 
.
 
300 cells per treatment in 3–4 replicates. Image analysis was
performed using the AnalySIS software (Soft Imaging Systems).
 
TUNEL Analysis
 
HeLa and KE37 cells were fixed with 3% paraformaldehyde. Fragmented
DNA was labeled with fluorescein-conjugated dUTP using the Boeh-
ringer In Situ Cell Death Detection Kit according to instructions. Cells
were examined by epifluorescence microscopy using an FITC filter, and
images were analyzed with the AnalySIS software.
 
Results and Discussion
 
Targeting of PP1 to the Nuclear Envelope by AKAP149 
at the End of Mitosis
 
We first tested the NE association of AKAP149 and PP1
in HeLa cells and human T lymphoblastic cells (line
KE37), which are deficient in lamins A/C. Both AKAP149
and PP1 were detected on Western blots of HeLa and
KE37 cell NEs (Fig. 1 A). In addition, PP1, lamin B, and
lamins A/C coprecipitated with anti-AKAP149 antibodies
from solubilized HeLa NEs (Fig. 1 A, left panel). PP1 and
lamin B also coprecipitated with AKAP149 from KE37
NEs (Fig. 1 A, right panel). Thus, AKAP149 interacts with
the nuclear lamina, and this interaction does not depend
on lamins A/C.
Whether AKAP149 was implicated in targeting PP1 to
Figure 1. AKAP149 targets PP1 to the nuclear envelope. (A)
PP1, lamin B, and lamins A/C coimmunoprecipitate with
AKAP149. NEs were purified from interphase HeLa or KE37
cells, solubilized, and AKAP149 was immunoprecipitated (IP).
Control immunoprecipitations were done using preimmune
mouse IgGs. Precipitates were analyzed by immunoblotting using
anti-AKAP149, anti-PP1, anti-lamin B and anti-lamins A/C anti-
bodies. (B) HeLa cells synchronized in mitosis were incubated
with PP1-BD(V155A) or PP1-BD. Excess peptide was removed
and cells were cultured for 2 h. Nuclei and NEs were purified, and
association of AKAP149 and PP1 with the NE was analyzed by
immunoblotting. (C) AKAP149 or PP1 were immunoprecipitated
from NEs solubilized from HeLa cells exposed to PP1-
BD(V155A) or PP1-BD. Immune precipitates were immunoblot-
ted using anti-AKAP149 or anti-PP1 antibodies. 
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the NE at the end of mitosis was investigated by introduc-
ing, into synchronized mitotic HeLa cells, a competitor
peptide containing the PP1-binding domain of AKAP149
(PP1-BD: SSPKGVLFSS), or a mutated control peptide
(PP1-BD[V155A]) that does not bind PP1 (Steen et al.,
2000). Peptides were mixed with the transfection reagent
DOTAP and introduced directly into cells synchronized in
mitosis. Cells were washed to remove unincorporated pep-
tide, and cultured for 2 h to allow exit from mitosis. Asso-
ciation of PP1 with purified NEs was assessed by immu-
noblotting. Fig. 1 B shows that whereas the control
PP1-BD(V155A) peptide did not impair association of PP1
with the NE, PP1-BD completely abolished NE targeting
of PP1. This was verified by the failure of AKAP149
and PP1 to coimmunoprecipitate from solubilized NEs,
whereas both proteins coprecipitated in control cells ex-
posed to PP1-BD(V155A) (Fig. 1 C). We concluded that
AKAP149 targets PP1 to the NE at the end of mitosis.
 
Failure to Recruit PP1 to the NE at the End of Mitosis 
Abolishes Assembly of B-type Lamins
 
To address the significance of PP1 targeting to the NE by
AKAP149, we introduced PP1-BD or the noncompetitor
PP1-BD(V155A) peptide into mitotic HeLa cells, and as-
sessed NE reassembly 2 h after exit from mitosis, by
immunofluorescence using antibodies against lamin B,
lamins A/C, and the inner nuclear membrane protein,
LBR. Strikingly, whereas control cells exposed to no pep-
tide, PP1-BD(V155A), or DOTAP alone displayed ex-
pected perinuclear staining of the three markers, the ma-
jority of cells exposed to PP1-BD (
 
.
 
80% out of 300
examined) reformed nuclei devoid of detectable lamin B
(Fig. 2 A). Little or no lamin B was detected in the cyto-
plasm of these cells (Fig. 2 A; see below). Nevertheless,
the cells displayed perinuclear staining of lamins A/C and
LBR (Fig. 2 A), indicating that these nuclei were enclosed
by an envelope. Further evidence for the assembly of nu-
Figure 2. Inhibition of PP1 targeting to the NE abolishes assembly of lamin B, but not lamins A/C or nuclear membranes. Mitotic HeLa
cells were exposed to no peptide, PP1-BD, PP1-BD(V155A), or the transfection reagent DOTAP alone, washed, and released from mi-
totic arrest for 2 h as in the legend to Fig. 1. (A) Distribution of lamin B, lamins A/C, and LBR was analyzed by immunofluorescence.
Arrow points to a PP1-BD–treated cell that probably escaped peptide inhibition and displayed lamin B staining. (B) Dual immunofluo-
rescence labeling of emerin (green) and lamin B (red) in HeLa cells exposed to PP1-BD or PP1-BD(V155A) as in A. Merged images
are shown. (C) Proteolysis of lamin B not assembled into the NE. Mitotic HeLa cells were exposed to no peptide, DOTAP alone, PP1-
BD, or PP1-BD(V155A) as in A, and extracts were immunoblotted using anti-LBR, anti-AKAP149, anti-lamins A/C, and anti-lamin B
antibodies. Dlamin B indicates a 45-kD lamin B fragment. (D) The caspase inhibitor zVAD-FMK prevents proteolytic degradation of
unassembled lamin B, but does not rescue nuclear reassembly of lamin B. Mitotic HeLa cells were treated with PP1-BD alone or to-
gether with 100 mM zVAD-FMK. Excess peptide was removed and cells were cultured for 2 h with zVAD-FMK. Proteolysis of lamin B
and PARP was analyzed by immunoblotting. (E) Distribution of lamin B in cells exposed to PP1-BD or PP1-BD plus zVAD-FMK was
examined by immunofluorescence (red). DNA was stained with Hoechst 33342 (blue). Bars, 10 mm. 
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clear membranes in the absence of lamin B targeting to
the NE was lent by dual immunofluorescence analysis of
another integral protein of the inner nuclear membrane,
emerin, and lamin B (Fig. 2 B). Additionally, Western
blotting analysis of PP1-BD–treated cells revealed that
LBR, AKAP149, and lamins A/C remained intact, as
judged by their expected migration in SDS-PAGE (Fig. 2
C). However, lamin B was proteolyzed into a 45-kD prod-
uct (Fig. 2 C, 
 
D
 
lamin B), reminiscent of the lamin B frag-
ment generated by caspase activity in apoptotic cultured
cells (Lazebnik et al., 1995; Takahashi et al., 1996). There-
fore, inhibition of PP1 targeting to the NE at the end of
mitosis abolishes nuclear assembly of lamin B, and elicits
its proteolysis. However, assembly of nuclear membranes
and lamins A/C is not affected. Moreover, the data argue
that LBR apparently does not depend on B-type lamins
for assembly into the NE.
The correlation between failure of lamin B assembly
and its degradation raised the issue of whether failure to
assemble was a due to degradation of the lamin or, con-
versely, whether it caused proteolytic processing of the
lamin. Fig. 2 D shows that lamin B degradation was pre-
vented in HeLa cells treated with PP1-BD together with
100 
 
m
 
M of the broad caspase inhibitor, zVAD-FMK, and
cultured for another 2 h with zVAD-FMK after release
from mitotic arrest. zVAD-FMK also inhibited proteolysis
of the control caspase 3 substrate, PARP, induced by PP1-
BD (Fig. 2 D). When lamin B distribution was examined
in cells exposed to PP1-BD or PP1-BD and zVAD-FMK,
we found that in neither case did the cells display perinu-
clear lamin B staining (Fig. 2 E). The labeling was distrib-
uted in the cytoplasm, in a punctate manner and with vari-
able intensity. These results indicate that lamin B that fails
to assemble into a lamina as a result of PP1-BD treatment
is proteolyzed in a caspase-sensitive manner. Caspase-
dependent degradation of unassembled lamin B is rapid,
and suggests that these cells entered apoptosis (see be-
low). Moreover, although lamin B degradation is pre-
vented with zVAD-FMK, its assembly into the NE re-
mains abolished with the PP1-BD peptide. We concluded
that lamin B failed to assemble into a nuclear lamina as a
consequence of inhibiting PP1 targeting to the NE, rather
than as a result of degradation of the lamin.
 
Mistargeting of PP1 and Lamin B by PP1-BD Is 
Followed by Apoptosis
 
HeLa cells exposed to PP1-BD as described above were
monitored at 6 h after release from mitotic arrest. DNA
staining revealed nuclear fragmentation in all cells (Fig. 3
A). Moreover, LBR, lamin B, and lamins A/C, normally
restricted to the NE in control cells (Fig. 3 A; bottom),
were redistributed into the cytoplasm after PP1-BD treat-
ment (top). No obvious alteration in AKAP149 distribu-
tion was observed, most likely owing to the NE-ER local-
ization of the protein in healthy cells.
LBR, lamin B, lamins A/C, and AKAP149 were exten-
sively proteolyzed in PP1-BD–treated cells (Fig. 3 B).
LBR was cleaved into a 20-kD fragment (
 
D
 
LBR), as in ap-
optotic avian cells (Duband-Goulet et al., 1998). Lamin B
remained as a 45-kD product, and lamins A/C were exten-
sively proteolyzed into labile products (Fig. 3 B) (see La-
 
zebnik et al., 1995 for proteolytic lamins A/C fragments).
Degradation of AKAP149 into a major 67-kD polypeptide
was also observed (Fig. 3 B), as well as complete proteoly-
sis of lamina-associated polypeptide 2
 
b
 
, another integral
protein of the inner nuclear membrane (data not shown).
TUNEL analysis revealed extensive DNA fragmen-
tation in nearly 100% of PP1-BD–, but not PP1-
BD(V155A)–treated cells (Fig. 3, C and D). This fragmen-
tation was inhibited with 100 
 
m
 
M zVAD-FMK (Fig. 3 D).
The similarity of nuclear events observed with the PP1-
BD peptide and in apoptotic cultured cells (Lazebnik et
al., 1995; Takahashi et al., 1996; Duband-Goulet et al.,
1998) establishes the apoptotic nature of cell death result-
ing from PP1 and lamin B mistargeting to the NE. This ob-
servation supports the view that B-type lamins are essen-
tial for cell survival. This is consistent with data from
 
Caenorhabditis elegans
 
, which encodes a single lamin of
B-type and exhibits a null lamin phenotype that is embry-
onic lethal (Liu et al., 2000). Note, however, that we do not
at present exclude the possibility that the PP1-BD inhibi-
tory peptide, by binding to PP1, sequesters the phos-
phatase and prevents it from dephosphorylating additional
targets that are directly responsible for inducing apoptosis.
 
Mistargeting of Lamin B in Lamins A/C–deficient 
Lymphoblastic Cells Elicits De Novo Synthesis of 
Lamins A/C
 
The effect of preventing lamin B assembly at the end of
mitosis in the lamins A/C–deficient KE37 cell line was in-
vestigated using the DOTAP-mediated peptide transfec-
tion approach developed for HeLa cells. As in HeLa cells,
exposure of mitotic KE37 cells to PP1-BD, but not PP1-
BD(V155A), abolished lamin B targeting to the NE (Fig. 4
A). As expected, no lamins A/C were detected in control
cells; however, PP1-BD–treated cells surprisingly dis-
played distinct perinuclear labeling of lamins A/C (Fig. 4
A). Synthesis of intact lamins A and C (apparent 
 
M
 
r
 
 70
and 60 kD, respectively) in PP1-BD–treated KE37 cells
was confirmed on immunoblots (Fig. 4 B). The blots also
showed proteolytic processing of lamin B, whereas LBR
and AKAP149 remained intact 2 h after mitotic release
(Fig. 4 B). Nevertheless, despite NE targeting of lamins
A/C, all KE37 cells exposed to PP1-BD underwent apoptosis
within 6 h of mitotic release (Fig. 4 C). This indicates that,
as in HeLa cells, inhibition of PP1 recruitment to the NE
by AKAP149 in KE37 cells abolishes lamin B assembly.
However, inhibition of lamin B assembly in KE37 cells
correlates with synthesis and nuclear assembly of lamins
A/C. Note that no alteration in the level of lamin A/C pro-
teins was detected upon inhibition of lamin B assembly in
HeLa cells (Fig. 2, A and C).
 
Differential Regulation of A/C- and B-type Lamins
 
Our results provide evidence for distinct pathways of as-
sembly of lamins A/C and B into the NE. Inhibition of
AKAP149-mediated PP1 targeting to the reforming NE
prevents assembly of B-type lamins, whereas that of
lamins A/C is not affected. Thus, only B-type lamins re-
quire AKAP149-mediated concentration of PP1 at the nu-
clear membrane for assembly. At mitosis, lamins A/C are
more soluble than B-type lamins (which remain mostly 
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Figure 3. Cells exposed to PP1-BD undergo apoptosis. (A) Mitotic HeLa cells exposed to PP1-BD or PP1-BD(V155A) were washed
and cultured for 6 h. Distribution of LBR, lamin B, lamins A/C, and AKAP149 was examined by immunofluorescence (red label). DNA
was stained with Hoechst 33342 (blue) to assess nuclear morphology. (B) Cells treated with PP1-BD or PP1-BD(V155A) were analyzed
by immunoblotting using anti-LBR, anti-lamin B, anti-lamins A/C, and anti-AKAP149 antibodies. (C) TUNEL analysis of HeLa cells
treated with PP1-BD or PP1-BD(V155A). Fluorescein dUTP label was colored in red and was merged with Hoechst DNA staining
(blue) in both panels. (D) Proportions of TUNEL-positive cells over time after exposure to either PP1-BD, PP1-BD(V155A), DOTAP
alone or PP1-BD plus 100 mM zVAD-FMK (mean 6 SD). Bars, 10 mm.
Figure 4. Synthesis of lamins A/C after in-
hibition of lamin B assembly by PP1-BD
in KE37 cells. (A) Mitotic KE37 cells were
exposed to either no peptide, PP1-BD, or
PP1BD(V155A), washed, and cultured for
2 h. Distribution of lamins B and A/C was
analyzed by dual immunofluorescence.
(B) Cells were also analyzed by immuno-
blotting using anti-lamin B, anti-lamins
A/C, anti-LBR, and anti-AKAP149 anti-
bodies. (C) TUNEL analysis of KE37 cells
exposed to PP1-BD or PP1-BD(V155A)
as in A. Insets, DNA staining with
Hoechst 33342. Bars, 10 mm. 
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membrane bound), and thus may not require spatially re-
stricted, elevated concentration of phosphatase activity to
be dephosphorylated and polymerize. Additional support
for a distinct assembly pathway for A- and B-type lamins
emerges from detailed imaging observations of transfected
lamins A and B1 assembly in living mammalian cells (Moir
et al., 2000). This study showed that whereas lamin B1
concentrates on the chromosome surface in telophase,
lamin A is first found in an unpolymerized form in the nu-
cleoplasm before polymerizing into the lamina (Goldman
et al., 1992; Moir et al., 2000). Moreover, A- and B-type
lamins bind to distinct ligands in the inner nuclear mem-
brane or the chromatin (Wilson, 2000), suggesting distinct
targeting during NE reformation. Recently identified
lamin-binding proteins such as Narf (Barton and Worman,
1999), AKAP149 (Steen et al., 2000), and lamina-associ-
ated polypeptide 2 isoforms (Dechat et al., 2000) suggest
that lamina dynamics may be regulated by components in
specific nuclear domains.
Differential assembly of A- and B-type lamins at the
end of mitosis raises the issue of whether the lamins de-
pend on each other for their assembly. Several nontermi-
nally differentiated cells only harbor B-type lamins (Guilly
et al., 1990; Lin and Worman, 1997); therefore, lamins A/C
are not required for lamin B assembly. Moreover, we show
that lamins A/C assemble even when NE targeting of
B-type lamins is abolished, and thus NE targeting of lamins
A/C does not require preassembly of a lamina structure.
Thus, it becomes clear that A- and B-type lamins do
not depend on each other for their assembly. Yet, lamin
B–deficient cells undergo apoptosis regardless of nuclear
assembly of lamins A/C, indicating that NE targeting of
B-type lamins is sine qua non for cell survival.
In contrast to the LMNB1 gene, the LMNA gene is dif-
ferentially expressed. Although both human LMNB1 and
LMNA genes lack typical TATA boxes in their 5
 
9
 
 proxi-
mal promoter regions, the LMNA gene contains two atyp-
ical TATA-like domains further upstream (Lin and Wor-
man, 1997). These regions may be target sites for negative
regulatory elements, as suggested by the role of 5
 
9
 
 proxi-
mal promoter regions in the cell type–specific transcrip-
tion of intermediate filament genes (Oshima, 1992). Un-
der normal conditions, the LMNA gene is not transcribed
in KE37 cells (Guilly et al., 1987). Our results suggest a
signaling mechanism that derepresses the LMNA gene in
response to a mislocalization of B-type lamins at the end
of mitosis. The interaction of lamins and lamin-binding
proteins with transcriptional activators (Cohen et al.,
2001) supports this attractive hypothesis.
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